Bacterial vaginosis and specific high-risk human papillomavirus genotype infection: a cross-sectional study in Nairobi, Kenya
Résumé
Background Emerging evidence indicates that bacterial vaginosis (BV) plays a role in high-risk Human Papillomavirus (hr-HPV) infection. However, the BV/hr-HPV association is still an under-explored concept in Africa, a region overburdened by the highest prevalence of both infections and cervical cancer in the world. Additionally, there is a significant knowledge gap regarding which specific hr-HPV genotypes contribute to this association in Africa. The objective of this study was to investigate whether BV is significantly associated with hr-HPV infection in Africa, with particular emphasis on the specific hr-HPV genotypes contributing to this association. Methods This publication is based on a cross-sectional analysis of baseline data from an ongoing cohort study. A total of 498 women met the eligibility criteria and were screened for BV, hr-HPV, and cervical lesions at baseline between July 2022 and November 2023. Logistic regression, C hi -square tests, and t tests were used to investigate associations among hr-HPV genotypes, BV, cytology results, and other risk factors. In all tests, a p -value of <0.05 was considered to indicate statistical significance. Results The BV infection and hr-HPV infection rates were 24.7% (123/498) and 28.1% (140/498), respectively. Almost one-tenth (49/498) of the enrolled women had BV/hr-HPV coinfection. A significant association between BV and pooled hr-HPV status (inclusive of the HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, -66, and -68 genotypes) was confirmed in this study (aOR = 2.38, 95% CI: 1.48–3.81), p < 0.001). BV was significantly associated with HPV-39 and HPV-52 genotypes (aOR: 3.23, 95% CI: 1.37–7.64, p = 0.007) and (aOR: 5.38, 95% CI: 1.17–24.74; p = 0.03), respectively. HPV-16 and HPV-68 were significantly associated with abnormal Pap smears ( p = 0.046 and p = 0.001, respectively). Conclusions BV was found to be significantly associated with pooled hr-HPV status, HPV-39, and HPV-52 infection in Kenyan women. These findings underscore the importance of treating BV promptly, as doing so may help minimize hr-HPV infection.
Citer ce document
Accès au document
Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter
Voir l'article sur le site de la revueStatistiques
Consultations : 1
Téléchargements : 0